Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
27 Diciembre 2024 - 4:23PM
Edgar (US Regulatory)
Exhibit 1
Joint Filing Agreement
The undersigned hereby agree as follows:
(i) Each of them is individually eligible to use the Schedule 13D to which this Exhibit is attached, and such Schedule 13D is filed on
behalf of each of them; and
(ii) Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and
accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to
believe that such information is inaccurate.
Date: December 27, 2024
|
|
Blue Horizon Enterprise Ltd.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Eleni Constantinou Kyriacou
|
|
|
|
Name:
|
Eleni Constantinou Kyriacou
|
|
|
|
Title:
|
Director
|
|
|
|
|
|
|
|
|
Ezbon International Limited
|
|
|
|
|
|
|
By:
|
/s/ Eleni Constantinou Kyriacou
|
|
|
|
Name:
|
Eleni Constantinou Kyriacou
|
|
|
|
Title:
|
Director
|
|
|
|
|
|
|
|
|
Montrago Trustees Limited
|
|
|
|
|
|
|
|
By:
|
/s/ Androulla Papadopoulou
|
|
|
|
Name:
|
Androulla Papadopoulou
|
|
|
|
Title:
|
Director
|
|
|
|
|
|
|
|
|
Skorpios Trust
|
|
|
|
|
|
|
By:
|
/s/ Androulla Papadopoulou
|
|
|
|
Name:
|
Androulla Papadopoulou
|
|
|
|
Title:
|
Director
|
|
Stoke Therapeutics (NASDAQ:STOK)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Stoke Therapeutics (NASDAQ:STOK)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
